LINC01592

Across TCGA pan-cancer cohorts, LINC01592 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC01592 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher LINC01592 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01592 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUSC show a favorable association.

KICH, KIRP, and STAD are the cancer types where LINC01592 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	All	0.710	1.000	<.001	129	view →
KIRP	OS	Tertile	II,III,IV	0.528	0.813	.003	79	view →
STAD	DFS	Median	II,III,IV	0.334	0.647	<.001	69	view →
BRCA	OS	Tertile	All	0.883	0.948	<.001	52	view →
BLCA	OS	Median	All	0.541	0.667	.005	46	view →
MESO	OS	Median	All	0.272	0.463	.001	36	view →
ESCA	DFS	Median	III,IV	0.554	0.331	.008	24	view →
COAD	OS	Tertile	All	0.719	0.826	.017	19	view →
KIRC	DFS	Quartile	IV	0.428	0.714	.013	12	view →
SKCM	DFS	Tertile	III,IV	0.350	0.539	.011	9	view →
LGG	OS	Tertile	All	0.702	0.827	.014	9	view →
UCEC	OS	Quartile	All	0.822	0.887	.031	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC01592–KICH (DFS)

Open the KICH breakdown →